Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 31 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06207305
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Carcinoma, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07693452
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Mucinous Neoplasm, +6 more
- Locations
-
- Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States
NCT07587268
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Adenocarcinoma, +16 more
- Locations
-
- City of Hope Medical Center Durate, California, United States
NCT05947838
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Adenocarcinoma, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04779554
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +22 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
- University of Vermont Medical Center Burlington, Vermont, United States
NCT06399757
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +46 more
- Locations
-
- City of Hope Duarte, California, United States
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
- Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
- University of Michigan Ann Arbor, Michigan, United States
Recruiting
UCSF PANC Cyst Registry
NCT04291651
- Conditions
- Adenoma, Cystadenoma, Cystadenoma, Serous, +21 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Recruiting
Genetics of Appendix Cancer Study
NCT05734430
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Adenocarcinoma, +28 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Not Yet Recruiting
TLR9 Immunotherapy for Peritoneal Carcinomatosis
NCT07658196
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +18 more
- Locations
-
- Rhode Island and the Miriam Hospitals (Brown University Health) Providence, Rhode Island, United States
Not Yet Recruiting
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
NCT06084780
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Carcinoma, +7 more
- Locations
-
- Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
NCT04814108
- Conditions
- Adenocarcinoma, Carcinoma, Cystadenocarcinoma, +6 more
- Locations
-
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Honor Health Phoenix, Arizona, United States
- Arizona Oncology Associates Wilmot HOPE Tucson, Arizona, United States
- Banner University Medical Center Tucson Tucson, Arizona, United States
NCT02101788
- Conditions
- Adenocarcinoma, Borderline Ovarian Serous Tumor, Carcinoma, +11 more
- Locations
-
- Tennessee Valley Gynecologic Oncology Huntsville, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Completed
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
NCT03108131
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendix Adenocarcinoma, +20 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
HIPEC for Peritoneal Carcinomatosis
NCT02040142
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +28 more
- Locations
-
- Department of Surgery, Montefiore Medical Center- Weiler Division The Bronx, New York, United States
NCT03602079
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
- Locations
-
- Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
- Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Clinical Research Alliance, Inc. Lake Success, New York, United States
Completed
Phase I Trial HIPEC With Nal-irinotecan
NCT04088786
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +26 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
- Stony Brook University Cancer Center Stony Brook, New York, United States
NCT01643460
- Conditions
- Adenocarcinoma, Adenoma, Carcinoma, +21 more
- Locations
-
- Indiana University Hospital Indianapolis, Indiana, United States
Completed
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
NCT00551070
- Conditions
- Adenocarcinoma, Borderline Ovarian Serous Tumor, Carcinoma, +11 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
NCT01126346
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +57 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
NCT02158039
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Cystic, Mucinous, and Serous, +1 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States